← Leaderboards
Fuliang Du
Evergen Biotechnologies, Inc.
$1,987,994
Attributed
$1,987,994
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $729.1K · FY2008–11$1M$750K$500K$250K$0
'08
'09
'10
'11
Funding mix
By agency
NIH$1,987,994 · 3
By mechanism
R44$1,873,234 · 2
R43$114,760 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Gene Targeting”
- David Heimbrook · Leidos Biomedical Research, Inc.$205,122,388
- Richard A Gibbs · Baylor College Of Medicine$161,086,449
- Barton F Haynes · Duke University$98,448,044
- Andrzej Joachimiak Joachimiak · University Of Chicago$94,692,413
- Eric Martin McDade · Washington University$94,632,845
- Stephen S. Rich · University Of Alabama At Birmingham$84,483,911
Research focus
Gene TargetingHuman DiseaseInhibitor/AntagonistAnimal ModelEmbryoGenesTransgenic OrganismsProductionCellsFibroblastsOryctolagus CuniculusKnock-OutBiotechnologyEvaluationBiological ModelsAnimalsGeneticDrug Delivery SystemsCardiovascular SystemCardiovascular PhysiologyCause Of DeathCell LineCommunitiesCardiovascular Diseases
Grant awards (5)
Derivation of germline competent rabbit embryonic stem cell lines$555,409
R44 · FY2011 · RR · contact PI
Novel Transgenic Rabbit Model for Cardiovascular Disease$588,734
R44 · FY2009 · HL · contact PI
Novel Transgenic Rabbit Model for Cardiovascular Disease$596,411
R44 · FY2008 · HL · contact PI
Novel Transgenic Rabbit Model for Cardiovascular Disease$132,680
R44 · FY2008 · HL · contact PI
Novel method to produce transgenic rabbits$114,760
R43 · FY2004 · RR